Search Results

There are 807843 results for: content related to: Highlights from the ASCO annual meeting

  1. You have free access to this content
    Poster

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 14, Issue S4, September 2016, Pages: 24–57,

    Version of Record online : 9 SEP 2016, DOI: 10.1111/ddg.13115

  2. You have full text access to this OnlineOpen article
    PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 36, Issue 3, March 2016, Pages: 317–334, Patrick J. Medina and Val R. Adams

    Version of Record online : 20 MAR 2016, DOI: 10.1002/phar.1714

  3. Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 35, Issue 10, October 2015, Pages: 963–976, Ninh M. La-Beck, Gary W. Jean, Cindy Huynh, Saeed K. Alzghari and Devin B. Lowe

    Version of Record online : 24 OCT 2015, DOI: 10.1002/phar.1643

    Corrected by:

    Erratum: Immune Checkpoint Inhibitors: New Insights and Current Place in Cancer Therapy

    Vol. 35, Issue 12, 1205, Version of Record online: 19 DEC 2015

  4. You have full text access to this OnlineOpen article
    PD-1 as a potential target in cancer therapy

    Cancer Medicine

    Volume 2, Issue 5, October 2013, Pages: 662–673, David F. McDermott and Michael B. Atkins

    Version of Record online : 21 JUL 2013, DOI: 10.1002/cam4.106

  5. Evaluation of Immunogenicity of Nivolumab Monotherapy and Its Clinical Relevance in Patients With Metastatic Solid Tumors

    The Journal of Clinical Pharmacology

    Shruti Agrawal, Paul Statkevich, Gaurav Bajaj, Yan Feng, Sally Saeger, Dharmesh D. Desai, Jong-Soon Park, Ian M. Waxman, Amit Roy and Manish Gupta

    Version of Record online : 27 SEP 2016, DOI: 10.1002/jcph.818

  6. Correlation between vitiligo occurrence and clinical benefit in advanced melanoma patients treated with nivolumab: A multi-institutional retrospective study

    The Journal of Dermatology

    Yasuhiro Nakamura, Ryota Tanaka, Yuri Asami, Yukiko Teramoto, Taichi Imamura, Sayuri Sato, Hiroshi Maruyama, Yasuhiro Fujisawa, Taisuke Matsuya, Manabu Fujimoto and Akifumi Yamamoto

    Version of Record online : 11 AUG 2016, DOI: 10.1111/1346-8138.13520

  7. You have free access to this content
    Checkpoint blocking antibodies in cancer immunotherapy

    FEBS Letters

    Volume 588, Issue 2, January 21, 2014, Pages: 368–376, Chrisann Kyi and Michael A. Postow

    Version of Record online : 23 OCT 2013, DOI: 10.1016/j.febslet.2013.10.015

  8. Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanoma

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 14, Issue 7, July 2016, Pages: 662–681, Katharina C. Kähler, Jessica C. Hassel, Lucie Heinzerling, Carmen Loquai, Rotraut Mössner, Selma Ugurel, Lisa Zimmer, Ralf Gutzmer and for the “Cutaneous Side Effects” Committee of the Work Group Dermatological Oncology (ADO)

    Version of Record online : 4 JUL 2016, DOI: 10.1111/ddg.13047

  9. Nebenwirkungsmanagement bei Immun-Checkpoint-Blockade durch CTLA-4- und PD1-Antikörper beim metastasierten Melanom

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 14, Issue 7, July 2016, Pages: 662–683, Katharina C. Kähler, Jessica C. Hassel, Lucie Heinzerling, Carmen Loquai, Rotraut Mössner, Selma Ugurel, Lisa Zimmer, Ralf Gutzmer and für das Komitee „Kutane Nebenwirkungen“ der Arbeitsgemeinschaft Dermatologische Onkologie (ADO)

    Version of Record online : 4 JUL 2016, DOI: 10.1111/ddg.13047_g

  10. Checkpoint-Inhibitoren in der Immuntherapie: Ein Meilenstein in der Behandlung des malignen Melanoms

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 14, Issue 7, July 2016, Pages: 685–697, Sophia M. Wilden, Berenice M. Lang, Peter Mohr and Stephan Grabbe

    Version of Record online : 4 JUL 2016, DOI: 10.1111/ddg.13012_g

  11. Autoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptions

    Journal of Cutaneous Pathology

    Volume 43, Issue 8, August 2016, Pages: 688–696, George Jour, Isabella C. Glitza, Rachel M. Ellis, Carlos A. Torres-Cabala, Michael T. Tetzlaff, Janet Y. Li, Priyadharsini Nagarajan, Auris Huen, Phyu P. Aung, Doina Ivan, Carol R. Drucker, Victor G. Prieto, Ronald P. Rapini, Anisha Patel and Jonathan L. Curry

    Version of Record online : 8 MAY 2016, DOI: 10.1111/cup.12717

  12. You have full text access to this OnlineOpen article
    Immunotherapy and Novel Combinations in Oncology: Current Landscape, Challenges, and Opportunities

    Clinical and Translational Science

    Volume 9, Issue 2, April 2016, Pages: 89–104, KM Morrissey, TM Yuraszeck, C-C Li, Y Zhang and S Kasichayanula

    Version of Record online : 30 MAR 2016, DOI: 10.1111/cts.12391

  13. You have full text access to this OnlineOpen article
    Myasthenic crisis and polymyositis induced by one dose of nivolumab

    Cancer Science

    Volume 107, Issue 7, July 2016, Pages: 1055–1058, Toshihiro Kimura, Satoshi Fukushima, Azusa Miyashita, Jun Aoi, Masatoshi Jinnin, Takayuki Kosaka, Yukio Ando, Masakazu Matsukawa, Hiroyuki Inoue, Kazuma Kiyotani, Jae-Hyun Park, Yusuke Nakamura and Hironobu Ihn

    Version of Record online : 15 JUL 2016, DOI: 10.1111/cas.12961

  14. You have free access to this content
    Poster Abstracts

    Asia-Pacific Journal of Clinical Oncology

    Volume 11, Issue S4, November 2015, Pages: 105–182,

    Version of Record online : 3 NOV 2015, DOI: 10.1111/ajco.12432_2

  15. Melanoma therapy: Check the checkpoints

    The Journal of Dermatology

    Volume 43, Issue 2, February 2016, Pages: 121–124, Masutaka Furue and Takafumi Kadono

    Version of Record online : 27 JAN 2016, DOI: 10.1111/1346-8138.13257

  16. You have free access to this content
    New drug targets in metastatic melanoma

    The Journal of Pathology

    Volume 232, Issue 2, January 2014, Pages: 134–141, Blanca Homet and Antoni Ribas

    Version of Record online : 10 DEC 2013, DOI: 10.1002/path.4259

  17. Systemic therapy of metastatic melanoma

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 13, Issue 12, December 2015, Pages: 1223–1237, Ricarda Rauschenberg, Marlene Garzarolli, Ursula Dietrich, Stefan Beissert and Friedegund Meier

    Version of Record online : 27 NOV 2015, DOI: 10.1111/ddg.12891

  18. Systemtherapie des metastasierten malignen Melanoms

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 13, Issue 12, December 2015, Pages: 1223–1238, Ricarda Rauschenberg, Marlene Garzarolli, Ursula Dietrich, Stefan Beissert and Friedegund Meier

    Version of Record online : 27 NOV 2015, DOI: 10.1111/ddg.150_12891

  19. Highlights of melanoma research presented at the 49th annual meeting of the American Society of Clinical Oncology in Chicago, 2013

    Pigment Cell & Melanoma Research

    Volume 27, Issue 1, January 2014, Pages: E1–E5, Clemens Krepler and Dorothee Herlyn

    Version of Record online : 1 NOV 2013, DOI: 10.1111/pcmr.12182

  20. Immune Checkpoint inhibitors: An introduction to the next-generation cancer immunotherapy

    The Journal of Clinical Pharmacology

    Volume 56, Issue 2, February 2016, Pages: 157–169, Lucy Lee, Manish Gupta and Srikumar Sahasranaman

    Version of Record online : 29 SEP 2015, DOI: 10.1002/jcph.591